Lack of carboplatin activity in malignant lymphomas

Eur J Cancer. 1996 Dec;32A(13):2370-1. doi: 10.1016/s0959-8049(96)00285-7.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Carboplatin / therapeutic use*
  • Humans
  • Lymphoma / drug therapy*
  • Middle Aged
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Carboplatin